Related references
Note: Only part of the references are listed.Adjuvant pegylated liposomal doxorubicin for older women with endocrine nonresponsive breast cancer who are NOT suitable for a standard chemotherapy regimen: The CASA randomized trial
Diana Crivellari et al.
BREAST (2013)
Predicting the risk of chemotherapy toxicity in older patients: The Chemotherapy Risk Assessment Scale for High-Age Patients (CRASH) score
Martine Extermann et al.
CANCER (2012)
Comparisons between different polychemotherapy regimens for early breast cancer: meta-analyses of long-term outcome among 100 000 women in 123 randomised trials
K. Albain et al.
LANCET (2012)
Management of elderly patients with breast cancer: updated recommendations of the International Society of Geriatric Oncology (SIOG) and European Society of Breast Cancer Specialists (EUSOMA)
Laura Biganzoli et al.
LANCET ONCOLOGY (2012)
Adjuvant chemotherapy in older women (ACTION) study - what did we learn from the pilot phase?
R. Leonard et al.
BRITISH JOURNAL OF CANCER (2011)
Quality of Life of Older Patients With Early-Stage Breast Cancer Receiving Adjuvant Chemotherapy: A Companion Study to Cancer and Leukemia Group B 49907
Alice B. Kornblith et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Predicting Chemotherapy Toxicity in Older Adults With Cancer: A Prospective Multicenter Study
Arti Hurria et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Adjuvant Chemotherapy in Older Women with Early-Stage Breast Cancer
Hyman B. Muss et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Weekly paclitaxel in the adjuvant treatment of breast cancer
Joseph A. Sparano et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Sequential adjuvant epirubicin-based and docetaxel chemotherapy for node-positive breast cancer patients:: The FNCLCC PACS 01 trial
Henri Roche et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Phase III trial comparing doxorubicin plus cyclophosphamide with docetaxel plus cyclophosphamide as adjuvant therapy for operable breast cancer
Stephen E. Jones et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Trastuzumab after adjuvant chemotherapy in HER2-positive breast cancer
MJ Piccart-Gebhart et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Adjuvant chemotherapy for elderly patients (≥70 years) with early high-risk breast cancer:: a retrospective analysis of 260 patients
A Brunello et al.
ANNALS OF ONCOLOGY (2005)
Adjuvant docetaxel for node-positive breast cancer
M Martin et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Compliance and toxicity of adjuvant CMF in elderly breast cancer patients: a single-center experience
E De Maio et al.
BMC CANCER (2005)
Weekly paclitaxel as first-line chemotherapy in elderly advanced breast cancer patients: a phase II study of the Gruppo Italiano di Oncologia Geriatrica (GIOGer)
L Del Mastro et al.
ANNALS OF ONCOLOGY (2005)
Adjuvant chemotherapy in elderly patients with breast cancer: a survey of the Breast International Group (BIG)
L Biganzoli et al.
ANNALS OF ONCOLOGY (2004)
Barriers to clinical trial participation by older women with breast cancer
MM Kemeny et al.
JOURNAL OF CLINICAL ONCOLOGY (2003)
Share Paper
